Drugs / azitromycine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00522821 | Nov 2007 → Jul 2014 | infectious disease, selective IgG subclass deficiency | Prothya Biosolutions | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT05480566 Background | Jun 2022 → Dec 2023 | chronic obstructive pulmonary disease | Hasselt University | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | azitromycine | “if not lorated: azitromycine” NCT00522821 ↗ |